Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.

[1]  Randall K Ten Haken,et al.  Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. , 2006, International journal of radiation oncology, biology, physics.

[2]  Laurence Court,et al.  Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. , 2006, International journal of radiation oncology, biology, physics.

[3]  P. van Luijk,et al.  Influence of adjacent low-dose fields on tolerance to high doses of protons in rat cervical spinal cord. , 2006, International journal of radiation oncology, biology, physics.

[4]  Helen H Liu,et al.  Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. , 2006, International journal of radiation oncology, biology, physics.

[5]  S. Swisher,et al.  Extended surgical staging for potentially resectable malignant pleural mesothelioma. , 2005, The Annals of thoracic surgery.

[6]  L. Marks,et al.  Challenges in defining radiation pneumonitis in patients with lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[7]  C. Thieke,et al.  Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience. , 2005, Lung cancer.

[8]  T. Guerrero,et al.  Extrapleural pneumonectomy followed by IMRT: Results of a phase I/II study , 2005 .

[9]  R. Fisher,et al.  Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. , 2005, International Journal of Radiation Oncology, Biology, Physics.

[10]  Andrew Jackson,et al.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. , 2004, International journal of radiation oncology, biology, physics.

[11]  Joe Y. Chang,et al.  Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest , 2003, Cancer journal.

[12]  K. Rosenzweig,et al.  Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. , 2003, International journal of radiation oncology, biology, physics.

[13]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Forster,et al.  Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. , 2003, International journal of radiation oncology, biology, physics.

[15]  K. Forster,et al.  Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. , 2003, International journal of radiation oncology, biology, physics.

[16]  C. Fiorino,et al.  Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. , 2002, International journal of radiation oncology, biology, physics.

[17]  R. Cameron,et al.  Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. , 2001, The Journal of thoracic and cardiovascular surgery.

[18]  M T Munley,et al.  Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. , 2001, International journal of radiation oncology, biology, physics.

[19]  K. Rosenzweig,et al.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. , 2001, The Journal of thoracic and cardiovascular surgery.

[20]  C C Ling,et al.  Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  V. Rusch,et al.  Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. , 1999, The Annals of thoracic surgery.

[22]  R K Ten Haken,et al.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.

[23]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[24]  R K Ten Haken,et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.

[25]  D. Sugarbaker,et al.  Patterns of failure after trimodality therapy for malignant pleural mesothelioma. , 1997, The Annals of thoracic surgery.

[26]  S. Steinberg,et al.  Surgically debulked malignant pleural mesothelioma: Results and prognostic factors , 1996, Annals of Surgical Oncology.

[27]  G. Kutcher,et al.  Technique for external beam treatment for mesothelioma. , 1987, International journal of radiation oncology, biology, physics.

[28]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.